PAVmed Inc. cash flow to debt ratio of -39.00K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

PAVmed Inc.'s free cash flow has decreased 15.39K% from $-33.61M last year to $-5.21G, signaling decreasing performance

PAVmed Inc.'s debt to equity ratio is 0.43, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

PAVmed Inc.'s debt has increased relative to shareholder equity from -12.77 last year to 0.43 today, signaling weakened financials

PAVmed Inc. has negative EBITDA, making leverage ratio unreliable

PAVmed Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

PAVmed Inc.'s profit margin has decreased (-1.75K%) in the last year from 1.33K% to -21.91K%, signaling decreasing performance

PAVmed Inc.'s short-term liabilities of $14.84M exceed its short-term assets of $2.56M, signaling financial risk

PAVmed Inc.'s return on assets of -41.01% is lower than the 5.00% threshold, indicating inefficient asset utilization

PAVmed Inc.'s return on equity of -49.65%, is lower than 15.00%, indicating bad performance

PAVmed Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

PAVmed Inc. had positive net income in only 2.00 out of 5 years, indicating unstable earnings

PAVmed Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

PAVmed Inc. has negative free cash flow, indicating cash burn

PAVmed Inc.'s yearly earnings has decreased -98.99% since last year from $39.79M to $401.00K, signaling decreasing performance

PAVmed Inc.'s yearly revenue has increased 2.27K% since last year from $3.00M to $71.00M, signaling increasing performance

ROIC -57.62% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

PAVmed Inc.'s 3-year revenue CAGR of -42.68% is negative, indicating declining revenue over the past 3 years

PAVmed Inc. had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance

PAVmed Inc. had positive ROE in only 1.00 out of 5 years, indicating inconsistent returns on equity

PAVmed Inc. has insufficient data to evaluate this check.

PAVmed Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

PAVmed Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

PAVmed Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

PAVmed Inc. has insufficient data to evaluate this check.

PAVmed Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

PAVmed Inc. has a price-to-book ratio of 0.36x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

PAVmed Inc. has a price-to-sales ratio of 105.39x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue